NCT01030315View on ClinicalTrials.gov

A Study of HM10760A (Long-acting Erythropoietin) in Healthy Adult Caucasian and Japanese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

October 31, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

January 31, 2011

Conditions
Healthy
Interventions
DRUG

HM10760A or placebo

Once, 0.04 mcg/kg to 2.0mcg/kg once intravenously

Trial Locations (1)

Unknown

Hanmi Clinical, US

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT01030315 - A Study of HM10760A (Long-acting Erythropoietin) in Healthy Adult Caucasian and Japanese Subjects | Biotech Hunter | Biotech Hunter